We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.71B
AUM Growth
+$133M
Cap. Flow
+$178M
Cap. Flow %
2.66%
Top 10 Hldgs %
26.7%
Holding
442
New
38
Increased
200
Reduced
128
Closed
18

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$44.9M
2
HSY icon
Hershey
HSY
+$33.9M
3
VTR icon
Ventas
VTR
+$33.1M
4
PAYX icon
Paychex
PAYX
+$31M
5
PEP icon
PepsiCo
PEP
+$26.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$54.8M
2
AAPL icon
Apple
AAPL
+$24M
3
O icon
Realty Income
O
+$21.6M
4
CFR icon
Cullen/Frost Bankers
CFR
+$17.6M
5
IBM icon
IBM
IBM
+$8.55M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Consumer Staples 15.49%
3 Technology 15.18%
4 Industrials 11.77%
5 Energy 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
51
BCE
BCE
$20.2B
$48.2M 0.72%
1,126,322
+29,861
+3% +$1.33M
KR icon
52
Kroger
KR
$35.4B
$47.7M 0.71%
1,833,116
-6,624
-0.4% -$167K
UNP icon
53
Union Pacific
UNP
$174B
$43M 0.64%
396,834
+1,338
+0.3% +$139K
EOG icon
54
EOG Resources
EOG
$79.2B
$40.8M 0.61%
412,205
-58,129
-12% -$6.32M
TUP
55
DELISTED
Tupperware Brands Corporation
TUP
$40.6M 0.61%
588,416
+6,344
+1% +$482K
MXIM
56
DELISTED
Maxim Integrated Products
MXIM
$37.3M 0.56%
1,234,805
+428,113
+53% +$13.5M
BDX icon
57
Becton Dickinson
BDX
$45.6B
$37.2M 0.55%
335,309
-12,381
-4% -$1.41M
SLB icon
58
SLB Ltd
SLB
$73.6B
$37M 0.55%
363,778
-2,076
-0.6% -$226K
HSY icon
59
Hershey
HSY
$35.2B
$35.5M 0.53%
372,396
+366,326
+6,035% +$33.9M
DOC icon
60
Healthpeak Properties
DOC
$15.1B
$35.3M 0.53%
976,384
+33,915
+4% +$1.29M
CHD icon
61
Church & Dwight Co
CHD
$23.4B
$34.7M 0.52%
987,810
-16,384
-2% -$558K
DOV icon
62
Dover
DOV
$27.6B
$33.8M 0.5%
520,444
-7,298
-1% -$514K
NKE icon
63
Nike
NKE
$61.9B
$32.1M 0.48%
720,658
-3,976
-0.5% -$158K
WFC icon
64
Wells Fargo
WFC
$261B
$30.6M 0.46%
589,139
+19,246
+3% +$990K
HD icon
65
Home Depot
HD
$331B
$30.2M 0.45%
328,891
+13,058
+4% +$1.12M
TWX
66
DELISTED
Time Warner Inc
TWX
$28.3M 0.42%
376,704
-7,634
-2% -$591K
XLNX
67
DELISTED
Xilinx Inc
XLNX
$27.2M 0.41%
642,873
+74,133
+13% +$3.24M
TROW icon
68
T. Rowe Price
TROW
$23.9B
$27M 0.4%
344,625
+36,140
+12% +$2.9M
CINF icon
69
Cincinnati Financial
CINF
$27.3B
$26.2M 0.39%
557,808
-7,914
-1% -$378K
SJM icon
70
J.M. Smucker
SJM
$12.7B
$26.2M 0.39%
264,928
+21,061
+9% +$2.16M
TFC icon
71
Truist Financial
TFC
$63.3B
$26.1M 0.39%
702,547
-12,571
-2% -$475K
TJX icon
72
TJX Companies
TJX
$174B
$25.3M 0.38%
854,176
-8,312
-1% -$234K
CMI icon
73
Cummins
CMI
$87.5B
$24.7M 0.37%
187,083
+372
+0.2% +$53.7K
EL icon
74
Estee Lauder
EL
$30.4B
$24.4M 0.36%
325,900
-7,607
-2% -$572K
AIT icon
75
Applied Industrial Technologies
AIT
$12.8B
$23.4M 0.35%
513,551
+1,620
+0.3% +$79.3K

Similar funds

Bahl & Gaynor's Q3 2014 Portfolio in Review

As of Q3 2014, Bahl & Gaynor held 442 positions worth $6.71B, up 2% from $6.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q3 2014 filing shows 38 new, 200 increased, 128 reduced and 18 closed positions. Its largest new stake was Cracker Barrel: 9,775 shares worth $1.01M. The largest sale was GSK, an estimated $54.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

  • Bahl & Gaynor's largest Q3 2014 buy was Cracker Barrel: 9,775 shares worth $1.01M.
  • Bahl & Gaynor added most to 3M in Q3 2014, an estimated $44.9M increase.
  • Bahl & Gaynor's biggest Q3 2014 reduction was GSK, cutting an estimated $54.8M.
  • Bahl & Gaynor fully exited GNC Holdings, Inc. in Q3 2014, selling an estimated $2.07M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.71B portfolio in Q3 2014.
  • Bahl & Gaynor opened 38 new positions and closed 18 in Q3 2014.
  • Bahl & Gaynor's portfolio value rose 2% quarter-over-quarter to $6.71B.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.